67
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Human neutrophil peptide in lung chronic allograft dysfunction

, , , &
Pages 663-669 | Received 25 Jul 2011, Accepted 12 Sep 2011, Published online: 11 Oct 2011

References

  • Aarbiou J, Ertmann M, van Wetering S, van Noort P, Rook D, Rabe KF, Litvinov SV, van Krieken JH, de Boer WI, Hiemstra PS. (2002a). Human neutrophil defensins induce lung epithelial cell proliferation in vitro. J Leukoc Biol 72:167–174.
  • Aarbiou J, Rabe KF, Hiemstra PS. (2002b). Role of defensins in inflammatory lung disease. Ann Med 34:96–101.
  • Aarbiou J, Verhoosel RM, Van Wetering S, De Boer WI, Van Krieken JH, Litvinov SV, Rabe KF, Hiemstra PS. (2004). Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 30:193–201.
  • Anderson RL, Hiemstra PS, Ward C, Forrest IA, Murphy D, Proud D, Lordan J, Corris PA, Fisher AJ. (2008). Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Eur Respir J 32:670–677.
  • Anyanwu AC, Rogers CA, Murday AJ. (1999). Review of the current state of thoracic transplantation: a national prospective cohort study. UK Cardiothoracic Transplant Audit Steering Group. Transplant Proc 31:165.
  • Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, Matsukura S. (2002). Elevated levels of alpha-defensins in plasma and BAL fluid of patients with active pulmonary tuberculosis. Chest 121:519–526.
  • Austin JH, Gougoutas CA & Schulman LL. (2000). Short air bubble in the gastric fundus during fasting: Radiographic sign of gastroparesis after lung transplantation. J Thorac Imaging 15:65–70.
  • Bals R, Hiemstra PS. (2004). Innate immunity in the lung: How epithelial cells fight against respiratory pathogens. Eur Respir J 23:327–333.
  • Belperio JA, DiGiovine B, Keane MP, Burdick MD, Ying Xue Y, Ross DJ, Lynch JP 3rd, Kunkel SL, Strieter RM. (2002a). Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients. Transplantation 73:591–599.
  • Belperio JA, Keane MP, Burdick MD, Londhe V, Xue YY, Li K, Phillips RJ, Strieter RM. (2002b). Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J Clin Invest 110:1703–1716.
  • Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Berlin A, Ross DJ, Kunkel SL, Charo IF, Strieter RM. (2001). Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome. J Clin Invest 108:547–556.
  • Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM. (2002c). Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 169:1037–1049.
  • Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, Shirakawa AK, Farber JM, Segal DM, Oppenheim JJ, Kwak LW. (2002). Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298:1025–1029.
  • Borregaard N, Elsbach P, Ganz T, Garred P, Svejgaard A. (2000). Innate immunity: From plants to humans. Immunol Today 21:68–70.
  • Boyton RJ, Openshaw PJ. (2002). Pulmonary defences to acute respiratory infection. Br Med Bull 61:1–12.
  • Chaly YV, Paleolog EM, Kolesnikova TS, Tikhonov II, Petratchenko EV, Voitenok NN. (2000). Neutrophil alpha-defensin human neutrophil peptide modulates cytokine production in human monocytes and adhesion molecule expression in endothelial cells. Eur Cytokine Netw 11:257–266.
  • Charpin JM, Stern M, Grenet D, Israël-Biet D. (2000). Insulinlike growth factor-1 in lung transplants with obliterative bronchiolitis. Am J Respir Crit Care Med 161:1991–1998.
  • Cole AM, Ganz T. (2000). Human antimicrobial peptides: Analysis and application. BioTechniques 29:822–6, 828, 830.
  • DiGiovine B, Lynch JP 3rd, Martinez FJ, Flint A, Whyte RI, Iannettoni MD, Arenberg DA, Burdick MD, Glass MC, Wilke CA, Morris SB, Kunkel SL, Strieter RM. (1996). Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: Role of IL-8. J Immunol 157:4194–4202.
  • Elssner A, Vogelmeier C. (2001). The role of neutrophils in the pathogenesis of obliterative bronchiolitis after lung transplantation. Transpl Infect Dis 3:168–176.
  • Estenne M, Hertz MI. (2002). Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 166:440–444.
  • Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. (2002). Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 21:297–310.
  • Ganz T. (2002a). Antimicrobial polypeptides in host defense of the respiratory tract. J Clin Invest 109:693–697.
  • Ganz T. (2002b). Immunology. Versatile defensins. Science 298:977–979.
  • Gimino VG, Lande JD, Berryman TR, King RA, Hertz MI. (2003). Gene Expression Profiling of Bronchoalveolar Lavage Cells in Acute Lung Rejection. Am J Respir Cell Mol Biol 168:1237–1242.
  • Hiemstra PS, van Wetering S, Stolk J. (1998). Neutrophil serine proteinases and defensins in chronic obstructive pulmonary disease: Effects on pulmonary epithelium. Eur Respir J 12:1200–1208.
  • Hiratsuka T, Mukae H, Iiboshi H, Ashitani J, Nabeshima K, Minematsu T, Chino N, Ihi T, Kohno S, Nakazato M. (2003). Increased concentrations of human beta-defensins in plasma and bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Thorax 58:425–430.
  • Ihi T, Nakazato M, Mukae H, Matsukura S. (1997). Elevated concentrations of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis 25:1134–1140.
  • Kelly KE, Hertz MI, Mueller DL. (1998). T-cell and major histocompatibility complex requirements for obliterative airway disease in heterotopically transplanted murine tracheas. Transplantation 66:764–771.
  • Meyer KC, Cardoni AL, Xiang Z, Cornwell RD, Love RB. (2001). Vascular endothelial growth factor in human lung transplantation. Chest 119:137–143.
  • Mukae H, Iiboshi H, Nakazato M, Hiratsuka T, Tokojima M, Abe K, Ashitani J, Kadota J, Matsukura S, Kohno S. (2002). Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis. Thorax 57:623–628.
  • Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH. (2005). Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 5:1705–1713.
  • Neurohr C, Huppmann P, Samweber B, Leuschner S, Zimmermann G, Leuchte H, Baumgartner R, Hatz R, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group. (2009). Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients. J Heart Lung Transplant 28:468–474.
  • Riise GC, Andersson BA, Kjellström C, Martensson G, Nilsson FN, Ryd W, Scherstén H. (1999). Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 14:1123–1130.
  • Riise GC, Kjellström C, Ryd W, Scherstén H, Nilsson F, Mårtensson G, Andersson BA. (1997). Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: A prospective, longitudinal study. Eur Respir J 10:1742–1746.
  • Riise GC, Williams A, Kjellström C, Schersten H, Andersson BA, Kelly FJ. (1998). Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung. Eur Respir J 12:82–88.
  • Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, McNeil KD, Reed EF, Reinsmoen NL, Scott JP, Studer SM, Tazelaar HD, Wallwork JL, Westall G, Zamora MR, Zeevi A, Yousem SA. (2007). Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26:1229–1242.
  • van Wetering S, Mannesse-Lazeroms SP, van Sterkenburg MA, Hiemstra PS. (2002). Neutrophil defensins stimulate the release of cytokines by airway epithelial cells: Modulation by dexamethasone. Inflamm Res 51:8–15.
  • van Wetering S, van der Linden AC, van Sterkenburg MA, de Boer WI, Kuijpers AL, Schalkwijk J, Hiemstra PS. (2000). Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins. Am J Physiol Lung Cell Mol Physiol 278:L51–L58.
  • Whitford HM, Orsida B, Pais M, Levvey B, Ward C, Reid S, Reid D, Williams TJ, Kotsimbos T, Walters EH, Snell GI. (2001). Bronchoalveolar lavage(BAL) neutrophilia in lung transplant recipients(LTR): Infection and bronchiolitis obliterans syndrome(BOS), the chicken or the egg? J Heart Lung Transplant 20:260.
  • Zhang Y, Wroblewski M, Hertz, MI, Wendt CH, Cervenka TM & Nelsestuen GL. (2006). Analysis of chronic lung transplant rejection by MALDI-TOF profiles of bronchoalveolar lavage fluid. Proteomis. 6:1001–1010.
  • Zheng L, Walters EH, Ward C, Wang N, Orsida B, Whitford H, Williams TJ, Kotsimbos T, Snell GI. (2000). Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Thorax 55:53–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.